Dapagliflozin preferentially reduces fibrosis biomarkers in chronic heart failure patients with high extracellular matrix remodeling activity
Year: 2026
Type: article
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7166468601
